AAO 2019

Findings from the phase 3 ALLEVIATE trial demonstrated that reproxalap 0.25% and 0.5% ophthalmic solution achieved the primary and key secondary end points in patients with allergic conjunctivitis.

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Sepetaprost 0.002% was found to…

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Intravitreal fluocinolone acetonide (FAc; Iluvien)…

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019.. SAN FRANCISCO – Administering phenylephrine/ketorolac 1%/0.3% intraocular solution…

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Higher doses of vascular endothelial…

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Tocilizumab was found to be…

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – A retrospective analysis presented at…

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Dexamethasone ophthalmic intracanalicular insert (Dextenza;…

Administration of intravenous ketorolac was associated with a reduction in postoperative pain in patients undergoing orbital surgery, according to findings from a study presented at the 2019 American Academy of Ophthalmology Meeting.

Latanoprostene bunod showed greater reduction in intraocular pressure (IOP) after 3 months compared to other treatments for open-angle glaucoma and ocular hypertension.